-+ 0.00%
-+ 0.00%
-+ 0.00%

Keros Therapeutics CFO Keith Regnante Resigns, Effective Aug. 3; VP Finance Annita Tanini Named Interim Principal Financial Officer

Benzinga·07/22/2026 20:49:23
Listen to the news

https://www.sec.gov/ix?doc=/Archives/edgar/data/1664710/000166471026000038/kros-20260717.htm